Epidermal Growth Factor Receptor Kinase Domain Duplication in Lung Adenocarcinoma with Response to Osimertinib: A Case Report and Literature Review
Liquid and tissue NGS should be used in combination to guide treatment and monitor treatment response. Osimertinib may be particularly effective in metastatic NSCLC with EGFR-KDD mutations.
Authors
- Matthew M. Mirsky (ORCID: https://orcid.org/0000-0001-8737-9882)
- Ankit Mangla (ORCID: https://orcid.org/0000-0002-6789-4315)
- Jenny Gong (ORCID: https://orcid.org/0000-0002-6595-8610)
Institutions
- University Hospitals of Cleveland (US)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1159/000545543
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00